Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05174> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05174 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05174 label "CX501 [drugbank:DB05174]" assertion.
- drugbank:DB05174 seeAlso DB05174 assertion.
- drugbank:DB05174 description "Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of the oesophagus. It is developed by Cellerix and is in phase I of clinical trials." assertion.
- drugbank:DB05174 identifier "drugbank:DB05174" assertion.
- drugbank:DB05174 title "CX501" assertion.
- drugbank:DB05174 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05174 drugbank_vocabulary:drugbank-id "DB05174" assertion.
- drugbank:DB05174 bio2rdf_vocabulary:x-identifiers.org DB05174 assertion.
- drugbank:DB05174 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05174" assertion.
- drugbank:DB05174 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05174 bio2rdf_vocabulary:identifier "DB05174" assertion.